Super‐Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer
Journal of Ultrasound in Medicine · 2024-06 · 43 (6) · 1099-1107
DOI: 10.1002/jum.16438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, online erschienen am 27.02.2024. Verfasst von Kenneth Hoyt. Beteiligte Einrichtung: Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Mice, Nude, Breast Neoplasms, Disease Models, Animal, Ultrasonography. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIBIB NIH HHS.
Abstract (Originalsprache)
Objective
Evaluate the use of super‐resolution ultrasound (SRUS) imaging for the early detection of tumor response to treatment using a vascular‐disrupting agent (VDA).
Methods
A population of 28 female nude athymic mice (Charles River Laboratories) were implanted with human breast cancer cells (MDA‐MB‐231, ATCC) in the mammary fat pad and allowed to grow. Ultrasound imaging was performed using a Vevo 3100 scanner (FUJIFILM VisualSonics Inc) equipped with the MX250 linear array transducer immediately before and after receiving bolus injections of a microbubble (MB) contrast agent (Definity, Lantheus Medical Imaging) via the tail vein. Following baseline ultrasound imaging, VDA drug (combretastatin A4 phosphate, CA4P, Sigma Aldrich) or control saline was injected via the placed catheter. After 4 or 24 hours, repeat ultrasound imaging along the same tumor cross‐section occurred. Direct intratumoral pressure measurements were obtained using a calibrated sensor. All raw ultrasound data were saved for offline processing and SRUS image reconstruction using custom MATLAB software (MathWorks Inc). From a region encompassing the tumor space and the entire postprocessed ultrasound image sequence, time MB count (TMC) curves were generated in addition to traditional SRUS maps reflecting MB enumeration at each pixel location. Peak enhancement (PE) and wash‐in rate (WIR) were extracted from these TMC curves. At termination, intratumoral microvessel density (MVD) was quantified using tomato lectin labeling of patent blood vessels.
Results
SRUS images exhibited a clear difference between control and treated tumors. While there was no difference in any group parameters at baseline (0 hour, P > .09), both SRUS‐derived PE and WIR measurements in tumors treated with VDA exhibited significant decreases by 4 ( P = .03 and P = .05, respectively) and 24 hours ( P = .02 and P = .01, respectively), but not in control group tumors ( P > .22). Similarly, SRUS derived microvascular maps were not different at baseline ( P = .81), but measures of vessel density were lower in treated tumors at both 4 and 24 hours ( P < .04). An inverse relationship between intratumoral pressure and both PE and WIR parameters were found in control tumors ( R 2 > .09, P < .03).
Conclusion
SRUS imaging is a new modality for assessing tumor response to treatment using a VDA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA.
- Department of Small Animal Clinical Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Kenneth Hoyt
Förderung
- NIH HHS
- NCI NIH HHS
- NIBIB NIH HHS
- National Institutes of Health
Zitieren
APA
Hoyt, K. (2024). Super‐Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer. Journal of Ultrasound in Medicine, 43(6), 1099-1107. https://doi.org/10.1002/jum.16438
Vancouver
Hoyt K. Super‐Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer. Journal of Ultrasound in Medicine. 2024;43(6):1099-1107. doi:10.1002/jum.16438
BibTeX
@article{Hoyt2024,
author = {Hoyt, Kenneth},
title = {Super‐Resolution Ultrasound Imaging for Monitoring the Therapeutic Efficacy of a Vascular Disrupting Agent in an Animal Model of Breast Cancer},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
volume = {43},
number = {6},
pages = {1099--1107},
doi = {10.1002/jum.16438}
}
EUVIMED